Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging by Li, Wei et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Journal of Cardiovascular Magnetic 
Resonance
Open Access Research
Early manifestation of alteration in cardiac function in dystrophin 
deficient mdx mouse using 3D CMR tagging
Wei Li1,4, Wei Liu5, Jia Zhong1,4 and Xin Yu*1,2,3,4
Address: 1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA, 2Department of Radiology, Case 
Western Reserve University, Cleveland, Ohio, USA, 3Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio, 
USA, 4Case Center for Imaging Research, Case Western Reserve University, Cleveland, Ohio, USA and 5Department of Biomedical Engineering, 
Washington University, St Louis, Missouri, USA
Email: Wei Li - wei.li2@case.edu; Wei Liu - wei.liu_1@philips.com; Jia Zhong - jia.zhong@case.edu; Xin Yu* - xin.yu@case.edu
* Corresponding author    
Abstract
Background: Duchenne muscular dystrophy (DMD) is caused by the absence of the cytoskeletal
protein, dystrophin. In DMD patients, dilated cardiomyopathy leading to heart failure may occur
during adolescence. However, early cardiac dysfunction is frequently undetected due to physical
inactivity and generalized debilitation. The objective of this study is to determine the time course
of cardiac functional alterations in mdx mouse, a mouse model of DMD, by evaluating regional
ventricular function with CMR tagging.
Methods: In vivo myocardial function was evaluated by 3D CMR tagging in mdx mice at early (2
months), middle (7 months) and late (10 months) stages of disease development. Global cardiac
function, regional myocardial wall strains, and ventricular torsion were quantified. Myocardial
lesions were assessed with Masson's trichrome staining.
Results: Global contractile indexes were similar between mdx and C57BL/6 mice in each age
group. Histology analysis showed that young mdx mice were free of myocardial lesions. Interstitial
fibrosis was present in 7 month mdx mice, with further development into patches or transmural
lesions at 10 months of age. As a result, 10 month mdx mice showed significantly reduced regional
strain and torsion. However, young mdx mice showed an unexpected increase in regional strain
and torsion, while 7 month mdx mice displayed similar regional ventricular function as the controls.
Conclusion: Despite normal global ventricular function, CMR tagging detected a biphasic change
in myocardial wall strain and torsion, with an initial increase at young age followed by progressive
decrease at older ages. These results suggest that CMR tagging can provide more sensitive
measures of functional alterations than global functional indexes in dystrophin-related
cardiomyopathies.
Background
Duchenne muscular dystrophy (DMD) is an X-linked
severe progressive muscle wasting disease, which affects
approximately 1 in 3500 male birth [1,2]. DMD is caused
by the deficiency of a cytoskeletal protein, dystrophin,
which is a component of the transmembrane dystrophin-
glycoprotein complex (DGC). DGC plays an important
role in maintaining the structural integrity of the cells by
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linking intracellular actin filaments to basal lamina [3,4].
The disruption of DGC structure due to dystrophin defi-
ciency leads to dilated cardiomyopathy (DCM) that may
occur during adolescence [5]. At an early stage, DMD
patients usually do not present clinical cardiac symptoms
because of their physical inactivity and generalized debil-
itation. However, a recent cardiovascular magnetic reso-
nance (CMR) tagging study suggests that abnormal
myocardial strain may develop long before the manifesta-
tion of global functional deterioration [6].
The mdx mouse carries a nonsense mutation in its dys-
trophin gene that eliminates the expression of the dys-
trophin protein. It thus has been a popular animal model
for studying the pathophysiology of DMD [7,8]. The mdx
mice exhibit many of the same histological features seen
in DMD, including the degeneration and necrosis of
myofibers with inflammatory infiltrates, followed by sub-
sequent regeneration. However, disease progression in
mdx mice is milder as compared to DMD patients. Only in
relatively older mdx mice are the progressive degenerative
changes observed [9]. Similarly, mdx mice manifest histo-
logical evidence of a cardiomyopathy, but no overt cardiac
dysfunction has been found in the young mdx mice.
Reduced global cardiac function [10] and dilated right
ventricles [11] were only documented in relatively older
mdx mice. In the current study, we sought to delineate
alterations in cardiac function and structure during the
course of DCM progression in mdx mice. Longitudinal
evaluation of 3D regional myocardial wall motion, a
potentially more sensitive measure of ventricular contrac-
tile behaviour, was performed with CMR tagging.
Methods
CMR
In vivo CMR was performed at the Biological MR Labora-
tory of Washington University Medical Center. Mdx mice
and their age-matched C57BL/6 wildtype controls of 2, 7
and 10 months of age underwent CMR on a 4.7 T Varian
INOVA system (Varian Associates, Palo Alto, CA)
equipped with a gradient insert (60 G/cm, 10 cm inner
diameter) as described previously [12]. A 2.5-cm surface
coil was used for the imaging of mice. Briefly, mice were
anesthetized with 0.7~1% isoflurane by a nose cone and
placed into the coil in prone position. Electrodes were
attached to front paws and the right leg for ECG gating
and monitoring of vital signs. The animals were kept
warm by blowing hot air into the magnet using a blow
dryer. The heat flow and anaesthesia level were manually
adjusted to keep the heart rate similar to that under con-
scious conditions. Animals were sacrificed at the end of
imaging protocol for histological analysis. A total of 42
mice were scanned. The animal protocol was approved by
the Animal Studies Committee of the Washington Univer-
sity Medical Center.
Tagged images of 5 short-axis (SA) slices were acquired
from base to apex. The tagging sequence used a SPAMM-
1331 sequence applied immediately after the ECG trigger,
followed by gradient-echo cine sequence. Repetition time
(TR) was adjusted according to the R-R interval of the
heart such that a total of 15 frames were acquired during
one cardiac cycle. Other imaging parameters were: echo-
time (TE), 3 msec; data matrix, 256 × 128; field of view
(FOV), 4 cm × 4 cm; slice thickness, 1 mm. Tag resolution
was 0.6 mm with tagline thickness ranging from 0.2 to 0.3
mm. The acquired k-space data were zero-filled to yield a
matrix size of 512 × 512, corresponding to an in-plane res-
olution of 78 μm × 78 μm. Two sets of tagged SA images
were acquired with tags in perpendicular directions for
each SA plane, yielding a grid tagging pattern when the
two data sets were combined. Tagged long-axis (LA)
images were acquired from four radially distributed LA
views spaced every 45°, with the tags perpendicular to the
LV long-axis. Imaging parameters were the same as those
used for SA images.
Regular cine images that provided better contrast between
the myocardium and the blood were acquired for mor-
phological analysis. These images were acquired with the
same imaging parameters as the tagged images with a 128
× 128 data matrix. Both the cine and the tagged images
were zero-filled into a 512 × 512 data matrix so that myo-
cardial contours traced from cine images were directly
used in the analysis of tagged images with minimal adjust-
ment. Total image acquisition time, including animal
setup, was ~2 hours.
Image Analysis
CMR data were analyzed with an in-house developed
MATLAB-based software (CVMRI) described previously
[12-15]. Epicardial and endocardial borders for SA images
were traced interactively for the calculation of stroke vol-
ume, ejection fraction, and wall thickness. The left ven-
tricular wall was further divided into four segments:
septum, posterior, lateral, and anterior. Taglines for both
SA and LA images were tracked semi-automatically with a
HARP-based approach (Fig. 1A, B). Reconstruction of the
3D tag points was performed by first registering the SA
and LA images in a 3D Cartesian coordinate system. Dis-
placement of the intersecting tag points were tracked
using an iterative point-tracking technique described pre-
viously [12]. The left ventricle was then divided into tetra-
hedrons using four non-coplanar adjacent tag points as
the vertices. The 3D Lagrangian strain tensor was calcu-
lated from the deformation of these tetrahedrons, which
was further diagonalized to yield principal strains E1, E2,
and E3, with E1 and E3 being the maximal and minimal
strains, respectively. The strain tensor was also trans-
formed into a local myocardial coordinate system defined
by the radial, circumferential, and longitudinal directions,Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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yielding three normal strains in the circumferential (Ecc),
radial (Err) and longitudinal (Ell) directions, respectively.
Myocardial twist was computed as the rotation angle
around the center of LV cavity (Fig. 1E &1F). Net twist
angle was defined as the difference between the ventricu-
lar twist at apical and basal slices. Torsion was calculated
as the net twist angle normalized by the slice separation.
Typical processing time for a complete dataset was ~3
hours.
Histology
Upon the completion of CMR, the mouse was sacrificed
with an overdose of KCl injection. The heart was excised
and fixed in neutral-buffered 10% formalin for histologi-
cal analysis. The fixed heart was sliced in 1-mm increment
from base to apex along the LV long-axis. Each slice was
embedded in paraffin and sectioned at 4 μm. Tissue sec-
tions were stained with Masson's trichrome for the identi-
fication of fibrotic lesions. The extent of myocardial
fibrosis was quantified from histological images using a
thresholding method developed in MATLAB (Fig. 2). Pix-
els representing fibrotic tissue were extracted from the dif-
ference image of the red and blue channels of the original
image, which provided the best contrast between normal
and fibrotic tissue (Fig. 2C). Total myocardial tissue (nor-
mal and fibrotic) was extracted from the grayscale image
(Fig. 2B). The percentage of tissue fibrosis was calculated
as the ratio of the pixel numbers representing fibrotic and
total myocardial tissue, respectively.
Statistics
Data are presented as mean ± standard deviation.
Unpaired Student t-test was used for comparisons
between mdx mice and their age-matched controls. Mean
values of myocardial strain in septal, anterior, lateral, and
posterior segments, or at basal, midventricular, and apical
levels, were compared separately by one-way analysis of
variance (ANOVA). If there were statistical differences,
multiple pairwise comparisons were performed using
Tukey's test with a confidence interval of 95%. P values
less than 0.05 were considered statistically significant.
3D MRI tagging image analysis Figure 1
3D MRI tagging image analysis. A&B. Tracking of taglines in tagged short- and long-axis images, respectively; C&D. Recon-
structed 3D tag points at end-diastole and end-systole, respectively; E&F. Trajectories of regional myocardial wall motion from 
end-diastole (dots) to end-systole (tails) at base and apex, respectively.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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Results
Animal Characteristics and Global Contractile Indexes
The animal characteristic data and global ventricular func-
tion measured from CMR are summarized in Table 1.
Heart rate was similar to that reported in the literature at
normal body temperature [16-18]. Heart rate, LV end-
diastolic volume (EDV), LV end-systolic volume (ESV),
stroke volume, ejection fraction and cardiac output were
all similar between mdx mice and their age-matched con-
trols in all three age groups. 10-month mdx mice showed
an increase in both heart weight and body weight, but
similar heart weight to body weight ratio. In addition,
there was also a slight increase in wall thickness in 10-
month mdx mice. However, the wall thickness to LV
diameter ratio was similar.
2-month mdx mice
Peak principal strain, normal strain, and ventricular tor-
sion are shown in Figs. 3, 4 and 5 respectively. 2-month
mdx mice had significantly increased regional wall strain
and torsion. Compared with the control mice, mdx mice
had a 12-44% increase in E2 (P < 0.05 in two apical slices),
a 9-16% increase in E3 (P < 0.05 in three midventricular
slices), and a 27-50% increase in Ecc (P < 0.05 for all 5
slices). Increased E1 was also observed in the slice between
the mid-ventricle and the base in mdx mice (P < 0.05).
Ventricular torsion was also significantly increased in mdx
Quantification of myocardial fibrosis Figure 2
Quantification of myocardial fibrosis. A. Original histological image; B. Binary image of total tissue; C. Quantification of 
fibrotic tissue within a selected region of interest. Upper panel: original image; mid panel: pseudo-colored image of the differ-
ence between the red and blue channels; lower panel: binary image of fibrotic tissue.
Table 1: Animal Characteristics and Morphological Data.
2 month 7 month 10 month
control (n = 8) mdx (n = 8) control (n = 5) mdx (n = 6) control (n = 7) mdx (n = 8)
Age, weeks 8.5 ± 1.3 9.2 ± 1.5 30.6 ± 1.8 33.7 ± 0.7 45.2 ± 2.8 43.5 ± 1.2
Body weight, g 26.9 ± 1.8 23.5 ± 4.1 32.2 ± 5.3 34.2 ± 1.0 30.0 ± 2.9 34.5 ± 2.0‡
Heart weight, mg 141 ± 20 127 ± 13 137 ± 6 158 ± 29 148 ± 12 170 ± 12‡
Heart weight/body weight, % 0.52 ± 0.05 0.55 ± 0.13 0.43 ± 0.06 0.46 ± 0.09 0.49 ± 0.03 0.49 ± 0.03
Heart rate, BPM 466 ± 42 441 ± 40 478 ± 38 481 ± 54 483 ± 29 500 ± 22
LV diameter, mm 5.37 ± 0.18 5.07 ± 0.35 5.43 ± 0.19 5.71+ 0.12 5.73 ± 0.25 5.75 ± 0.08
Wall thickness, mm 0.97 ± 0.16 0.81 ± 0.05 1.02 ± 0.08 1.04 ± 0.09 0.94 ± 0.04 1.04 ± 0.09*
Wall thickness/diameter 0.18 ± 0.03 0.16 ± 0.01 0.20 ± 0.03 0.18 ± 0.02 0.17 ± 0.01 0.19 ± 0.02
LVEDV, μl 42.8 ± 6.7 40.6 ± 7.4 42.1 ± 7.4 48.2 ± 6.7 51.0 ± 7.2 47.8 ± 4.2
LVESV, μl 15.3 ± 5.0 13.7 ± 3.5 18.6 ± 8.4 20.9 ± 5.3 24.0 ± 6.7 24.3 ± 2.9
Stroke volume, μl 27.5 ± 3.1 26.9 ± 4.3 25.9 ± 0.5 27.3 ± 2.3 27.0 ± 3.2 23.5 ± 3.1
Ejection fraction, % 65 ± 7 66 ± 4 63 ± 10 57 ± 5 54 ± 8 49 ± 5
Cardiac output, ml/min 12.9 ± 1.5 11.8 ± 1.6 12.7 ± 0.9 13.4 ± 1.3 13.0 ± 2.2 11.7 ± 1.4
*P < 0.05, ‡P < 0.01 between mdx mice and age matched controls.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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mice. The maximal torsion increased from 2.55 ± 0.41°/
mm in control mice to 3.40 ± 0.83°/mm in mdx mice (P
< 0.05).
7-Month Mdx Mice
7-month mdx mice had similar regional strain and time
course of ventricular torsion as the controls. The maximal
torsion of mdx mice was also similar to the controls (2.55
± 0.25 °/mm v.s. 3.06 ± 0.97°/mm, P = 0.3).
10-Month Mdx Mice
10-month mdx mice had significantly decreased regional
myocardial wall strains (E1, E2, E3, Ecc, Err and Ell) by
11~38% throughout the whole left ventricle, with the
exception of E1 at base, Ell at midventricle, and Err at both
apex and base. The time course of ventricular torsion was
significantly altered in mdx mice (Fig. 5C). The maximal
torsion decreased from 2.65 ± 0.86°/mm in the control
mice to 1.66 ± 0.40°/mm in mdx mice (P < 0.05).
Histological Analysis and Principal Strains in Segmented 
Regions
Representative histological images are shown in Fig. 6. 2-
month mdx hearts did not show obvious cardiac lesions
(0.6 ± 0.5%). 7-month mdx hearts had mild interstitial
fibrotic lesions (3.8 ± 1.1%). 10-month mdx hearts had a
wide range of tissue fibrosis from interstitial to transmural
fibrotic patches. The fibrotic tissue averaged 7.6 ± 3.9% in
10-month mdx mice. The fibrotic tissue displayed a ran-
dom and scattered pattern. Myocardial fibrosis was
observed in the septum, anterior, posterior and lateral seg-
ments of the left ventricle, as well as in the right ventricle.
Principal strains at apex, mid-ventricle, and base are
shown in Fig. 7. For 2-month mdx mice, anterior E1 strain
was decreased and lateral E2 strain was increased in the
apex, posterior E2 and E3 strains were increased in mid-
ventricle, as well as posterior E2 strain in the base (P <
0.05). For 7-month mdx mice, septum E1  strain was
Peak principal strains Figure 3
Peak principal strains. Peak E1 (A), E2 (B), and E3 (C) strains in 5 short-axis levels from apex (A), to mid-ventricle (M), and to 
base (B). *P < 0.05, ‡P < 0.01 between mdx mice and age-matched controls, respectively.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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increased at the apex, while lateral E3 strain was decreased
in mid-ventricle. At 10 months of age, all the segments
showed either a decrease or a trend towards decrease in
three principal strains in mdx mice. Consistent with the
scattered fibrosis, all four segments of the left ventricle
had a decrease in wall strain in 10-month mdx mice.
Discussion
In this study in mdx mice, we assessed the alterations in
regional left ventricular function at different stages of dis-
ease development towards DCM. Despite similar global
functional indexes, both young and adult mdx mice man-
ifested significantly altered patterns of regional ventricular
wall motion. Consistent with the development of fibrotic
lesions, myocardial wall strain and torsion were signifi-
cantly decreased in 10-month mdx mice. However, the
lesion-free young mdx mice had a surprising increase in
regional wall strain and torsion, while 7-month mdx mice
had similar contractile patterns as the controls.
Cardiac function has been investigated in mdx mice using
both CMR and echocardiography. Young mdx mice exhib-
ited normal morphology and global cardiac function
[10,19]. At 8 months of age, mdx mice started to manifest
right ventricular dilatation and decreased peak LV filling
rate [11]. However, ejection fraction and cardiac output in
mdx mice remained normal until 42 weeks of age [10,11].
While the normal global function in young and adult mdx
mice is consistent with these previous findings, our study
is the first to observe an early change in regional myocar-
dial wall strain and torsion in mdx mice. Our results sug-
gest that changes in regional wall motion can occur at a
very early age in mdx mice before any macroscopic and
global functional changes have occurred.
Peak normal strains Figure 4
Peak normal strains. Peak circumferential (A), longitudinal (B), and radial (C) strains in 5 short-axis levels from apex (A), to 
mid-ventricle (M), and to base (B). *P < 0.05, ‡P < 0.01 between mdx mice and age-matched controls, respectively.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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We observed a biphasic change in myocardial wall strain
and torsion in mdx mice, with an initial increase at young
age followed by decrease at older ages. Since dystrophin
disruption renders mdx mice more vulnerable to mechan-
ical stress and workload induced damage [20], the early
increase in myocardial contraction may lead to increased
ventricular wall stress in mdx mice, thus exacerbating
stress-induced damage and triggering the initial remode-
ling processes that eventually leads to lesion development
and cardiac dysfunction. The accumulation of tissue fibro-
sis leads to progressive decline in regional ventricular
function in older mdx mice. As a result, 7-month mdx
mice had similar regional ventricular function compared
with the controls, while 10-month mdx mice had signifi-
cantly decreased wall strain and torsion.
Cellular changes in mdx mice have also been investigated.
In particular, the impact of dystrophin deficiency on Ca2+
homeostasis has been investigated in both young (2-3
months) and adult (9-12 months) mdx mice by Williams
et al [21]. They observed significantly increased Ca2+ tran-
sient in both young and adult mdx mice, which was asso-
ciated with increased expression of ryanodine receptor,
the protein responsible for calcium release during systole.
As Ca2+ is the central regulator of myocyte contractility, it
is possible that our observed functional increase in young
mdx mice is attributable to enhanced myocyte contraction
due to increased Ca2+ transients. However, further investi-
gation is needed to establish the relationship of calcium
transients, myocardial contractile function, and disease
progression in mdx mice.
The effects of increased Ca2+ transients on myocardial
remodelling have been investigated in other animal mod-
els. Increased Ca2+ transients and myocyte hypertrophy
were observed in mice with β2-adrenoceptor overexpres-
sion [22]. Increase in Ca2+ transients via systemic β-ago-
nist administration has also been shown to cause myocyte
hypertrophy and apoptosis, tissue fibrosis, and heart fail-
ure [23]. All these studies indicate a possible mechanism
leading to myocardial dysfunction via chronic elevation
of Ca2+ transients. Interestingly, altered Ca2+ homeostasis
was also observed in the skeletal muscle of both mdx mice
and DMD patients [24-26]. These observations led to sev-
eral clinical trials that evaluated the effects of Ca2+ antag-
onists on DMD patients [27], with the primary focus on
the skeletal muscle. In general, no significant beneficial
effects were observed on the skeletal muscle function in
DMD patients, although reduced muscle degeneration
was revealed in several animal studies [28-30]. Only one
study reported a significant improvement in muscle
strength in verapamil-treated DMD patients, but with a
high incidence of cardiac side effects [31]. Since Ca2+ can
impact both inotropic and chronotropic state of the heart,
the effects of Ca2+ antagonists on the heart need to be care-
fully examined.
Several studies have investigated LV function in DMD
patients in search for early signs of myocardial dysfunc-
tion. Using CMR, Ashford et al reported normal LV vol-
ume and ejection fraction in young DMD patients.
However, CMR tagging revealed significantly reduced cir-
cumferential strain in these patients [6]. Similar findings
were reported using ultrasound-based methods. Mertens
et al investigated a group of young DMD patients with
preserved global function by echocardiography [32]. They
observed significantly decreased peak radial and longitu-
dinal systolic strain and strain rate, as well as peak systolic
and early diastolic myocardial velocities in the anterola-
teral and inferolateral LV walls. Similarly, Mori et al
reported decreased peak systolic radial strain and early
Time course of ventricular torsion Figure 5
Time course of ventricular torsion. A. Increased ven-
tricular torsion in 2-month mdx mice; B. Similar ventricular 
torsion between mdx and control mice at 7 month; C. 
Decreased ventricular torsion in 10-month mdx mice. *P < 
0.05, ‡P < 0.01 between mdx mice and age-matched controls, 
respectively.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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diastolic wall-thinning velocity in the posterior LV wall of
young DMD patients with normal conventional echocar-
diographic findings [33,34]. These studies suggest that
DMD patients manifest decreased regional myocardial
wall motion at an early age, which differ from the biphasic
change we observed in mdx mice. Compare to DMD
patients, the expression of disease in mdx mice is rela-
tively milder [35]. One possible explanation for this dif-
ference between mdx mice and DMD patients is that a
dystrophin analogue, utrophin, compensates for the lack
of dystrophin more effectively in mdx mice than in DMD
patients. Utrophin is associated with the DGC, and is sim-
ilar to dystrophin in primary sequence and predicted sec-
ondary structure [36]. It can compensate for dystrophin
when expressed at high levels. The severity of disease in
mice lacking both dystrophin and utrophin is similar to
DMD [37,38]. Further, a recent gene array study has con-
firmed the up-regulation of utrophin in mdx mice [39].
While the observed biphasic change in mdx mice suggests
that tissue tagging is more sensitive for detecting func-
tional alterations than global clinical indexes, functional
assessment alone may not be sufficient in delineating dis-
ease progression when opposing effects exist. The seem-
ingly "normal" regional wall motion in 7-month mdx
mice reflects the balance between increased myocyte con-
Histological assessment of mdx mouse hearts Figure 6
Histological assessment of mdx mouse hearts. Representative images of Masson's trichrome staining of mdx mouse 
hearts at 2 (A), 7 (B), and 10 (C) months of age. D. Quantification of fibrotic tissue at five short-axis levels from apex (A) to 
midventricle (M), and to base (B). ‡P < 0.01 between 2- and 7-month mdx mice. *P < 0.05, †P < 0.01 between 7- and 10-month 
mdx mice, respectively.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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tractility and the development of myocardial fibrosis.
Because of these counteracting factors, it is important to
evaluate other aspects of myocardial remodeling. In par-
ticular, late gadolinium enhanced CMR (LGE-CMR) has
been shown to detect myocardial lesions in DMD patients
[40-42]. The combination of LGE-CMR and tissue tagging
will provide more comprehensive evaluation of disease
progression in DMD patients.
Despite significant alterations in ventricular torsion and
wall strain at both 2- and 10-months of age, mdx mice
showed no statistical difference in global ventricular func-
tion compared to the age-matched controls. The relation-
ship between regional myocardial wall motion and global
ventricular function is complicated because of the intri-
cate 3D architecture of myocardial fibers. While CMR tag-
ging measures the regional deformation of the
myocardium, it remains to be elucidated to what extent
altered myocardial deformation can be reflected in global
changes in ventricular volumes. In general, current find-
ings support the notion that regional alterations precede
the manifestation of global functional changes. However,
a more quantitative relationship between regional wall
deformation and global ventricular function remains to
be defined.
Nevertheless, older mdx mice showed a trend towards
decreased ejection fraction (Table 1). Correlation analysis
revealed a weak, negative correlation between tissue fibro-
sis and ejection fraction (Fig. 8). A recent study of DMD
patients also investigated the correlation between ejection
fraction and myocardial lesion delineated by LGE [42].
Although a reduction in ejection fraction was reported in
DMD patients with significant lesion development (21.9
± 11.1%), no statistical significance was detected in age-
adjusted correlation between ejection fraction and lesion
size (P = 0.065). The mdx mice differ from DMD patients
with delayed disease progression. With an average fibrosis
of 7.6 ± 3.9% in 10-month mdx mice, the reduction in
ejection fraction was insignificant. These data further sug-
gest that analysis of regional myocardial wall motion can
provide more sensitive measures of functional alterations
in heart.
Previous LGE-CMR studies have identified the basal infe-
rior and lateral walls as the initial sites of myocardial
fibrosis [41,42]. A recent echocardiographic study also
observed decreased radial strain in the posterior wall with
relative sparing of ventricular septum [34]. However, such
preferential changes were not observed by CMR tagging
[6]. These discrepancies and the complicated relationship
between myocardial fibre structure and regional function
warrant further investigation. In the current study, we
observed atypical patterns of lesion distribution and func-
tional alterations in mdx mice. It remains to be investi-
gated which pathogenic processes are responsible for the
Principal strains in segmented regions Figure 7
Principal strains in segmented regions. S, septum; P, posterior; L, lateral; A, anterior. *P < 0.05, ‡P < 0.01 between mdx 
mice and age-matched controls, prespectively.Journal of Cardiovascular Magnetic Resonance 2009, 11:40 http://www.jcmr-online.com/content/11/1/40
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observed difference between mdx mice and DMD
patients.
One limitation of the current study is that different ani-
mals were characterized in different age groups because of
the requirement for histological analysis, which may
potentially increase the variability of strain measure-
ments. Heart rate variation during long image acquisition
can be a source of error for the 3D reconstruction of the
taglines. In the current study, this error was minimized by
maintaining a constant heart rate with 4.1 ± 4.7% fluctu-
ation. The TR was also adjusted according to the R-R inter-
val such that each of the 15 frames was acquired at the
same stage during a cardiac cycle. These measures can
effectively minimize the errors due to heart rate fluctua-
tion. The strain and torsion values in the control mice
were similar to those reported in the literature [16,43].
Taglines were tracked semi-automatically with HARP-
based method and homogeneous strain analysis was used
for strain quantification in the current study. While the fil-
tering of harmonic peaks in the k-space reduces the reso-
lution of reconstructed HARP images, the accuracy of
tagline tracking is not affected by k-space sampling/under-
sampling. The accuracy of homogeneous strain analysis
was investigated previously using a deformable silicone
gel phantom [44]. It has been shown that the error of
noise-free strain estimation was within 10% of the model-
calculated values, with no bias. With only one adjacent
slice, strain quantification at apex showed a larger varia-
tion than at mid-ventricle as fewer tetrahedrons were gen-
erated. However, average strain values for each
experimental group showed comparable standard devia-
tions at apex, base, and mid-ventricle, suggesting that dif-
ferences among animals were the dominant source of data
variation.
Conclusion
Despite normal global LV function, mdx mice had a
biphasic change in myocardial wall strain and torsion,
with an initial increase at young age followed by progres-
sive decrease at older ages. These results suggest that
regional LV function by CMR tagging is sensitive to early
signs of myocardial dysfunction than global functional
indexes. Therefore, CMR tagging can be utilized to detect
early cardiac involvement, as well as to potentially moni-
tor and quantify the effects of novel therapeutic interven-
tions in DMD patients.
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